{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:37:43Z","timestamp":1793137063080,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcv.2023.105469","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:30:48Z","timestamp":1682429448000},"page":"105469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis"],"prefix":"10.1016","volume":"164","author":[{"given":"Hana","family":"Elasifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Maija N","family":"Amukwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna M","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2023.105469_bib0001","series-title":"Biology of the Human Papillomavirus Life Cycle: The Basis For Understanding the Pathology of PreCancer and Cancer","first-page":"67","author":"Doorbar","year":"2020"},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0002","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jcv.2023.105469_bib0003","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2020.02.008","article-title":"Primary HPV screening for cervical cancer","volume":"65","author":"Bhatla","year":"2020","journal-title":"Best Pract. Res. Clin. Obstetr. Gynaecol."},{"key":"10.1016\/j.jcv.2023.105469_bib0004","first-page":"2019","article-title":"Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination\u2014Review of current perspectives","author":"Chan","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.jcv.2023.105469_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2022.101734","article-title":"Cost and effectiveness of HPV vaccine delivery strategies: a systematic review","author":"Akumbom","year":"2022","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.jcv.2023.105469_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104958","article-title":"Pan Q. cfDNA detection for HPV+ squamous cell carcinomas","volume":"115","author":"Chatfield-Reed","year":"2021","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-021-01095-5","article-title":"Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction","volume":"13","author":"Nassar","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jcv.2023.105469_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.csbj.2018.10.002","article-title":"Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management","volume":"16","author":"Elazezy","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150197","article-title":"Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC)","volume":"11","author":"Sherwood","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2023.105469_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2019.03.005","article-title":"Liquid biopsy of HPV DNA in cervical cancer","volume":"114","author":"Cheung","year":"2019","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224001","article-title":"Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: a meta-analysis","volume":"15","author":"Gu","year":"2020","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jcv.2023.105469_bib0012","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/coa.13136","article-title":"Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"43","author":"Jensen","year":"2018","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.jcv.2023.105469_bib0013","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fonc.2020.00505","article-title":"Next generation sequencing assay for detection of circulating HPV DNA (cHPV-DNA) in patients undergoing radical (Chemo)radiotherapy in anal squamous cell carcinoma (ASCC)","volume":"10","author":"Lee","year":"2020","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.jcv.2023.105469_bib0014","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-19-2384","article-title":"HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","volume":"27","author":"Leung","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.jcv.2023.105469_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jcv.2023.105469_bib0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cjp2.47","article-title":"Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma","volume":"2","author":"Jeannot","year":"2016","journal-title":"J. Pathol. Clin. Res."},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2001.6289","article-title":"Low incidence of HPV DNA in sera of pretreatment cervical cancer patients","volume":"82","author":"Liu","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijgo.2006.08.012","article-title":"Detection and typing of minimal human papillomavirus DNA in plasma","volume":"96","author":"Wei","year":"2007","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0019","first-page":"163","article-title":"Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer","volume":"12","author":"Jaberipour","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0020","first-page":"3","article-title":"Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma","volume":"11","author":"Dong","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"14","key":"10.1016\/j.jcv.2023.105469_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cells11142170","article-title":"The diagnostic value of circulating cell-free HPV DNA in plasma from cervical cancer patients","volume":"11","author":"Bonlokke","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0022","article-title":"Detection of circulating HPV16 DNA as a biomarker for cervical cancer by a bead-based","volume":"10","author":"Galati","year":"2022","journal-title":"HPV Genotyp. Assay. Microbiol."},{"issue":"6","key":"10.1016\/j.jcv.2023.105469_bib0023","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/1535370220978899","article-title":"Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker","volume":"246","author":"Rungkamoltip","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"12","key":"10.1016\/j.jcv.2023.105469_bib0024","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.tranon.2019.08.011","article-title":"A CRISPR test for detection of circulating nuclei acids","volume":"12","author":"Tsou","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jcv.2023.105469_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-1-2","article-title":"Human papillomavirus DNA in plasma of patients with cervical cancer","volume":"1","author":"Pornthanakasem","year":"2001","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jcv.2023.105469_bib0026","first-page":"1344","article-title":"Clinical significance of serum human papillomavirus DNA in cervical carcinoma","volume":"102","author":"Hsu","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.jcv.2023.105469_bib0027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2003.09.006","article-title":"Human papillomavirus DNA in sera of cervical cancer patients as tumor marker","volume":"202","author":"Widschwendter","year":"2003","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.jcv.2023.105469_bib0028","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2004.03.013","article-title":"HPV DNA in plasma of patients with cervical carcinoma","volume":"31","author":"Sathish","year":"2004","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2023.105469_bib0029","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/ijgc-00009577-200409000-00025","article-title":"Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer","volume":"14","author":"Yang","year":"2004","journal-title":"Int. J. Gynecol. Cancer Offic. J. Int. Gynecol. Cancer Soc."},{"issue":"5","key":"10.1016\/j.jcv.2023.105469_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyp193","article-title":"Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer","volume":"40","author":"Shimada","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.jcv.2023.105469_bib0031","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/1078-0432.CCR-17-1553","article-title":"Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring","volume":"23","author":"Kang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2023.105469_bib0032","article-title":"Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation","volume":"2","author":"Han","year":"2018","journal-title":"JCO Precis. Oncol."},{"issue":"3","key":"10.1016\/j.jcv.2023.105469_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100154","article-title":"HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer","volume":"6","author":"Cabel","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.jcv.2023.105469_bib0034","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-21-0625","article-title":"Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer","author":"Jeannot","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2022.07.028","article-title":"Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer","volume":"167","author":"Sivars","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.jcv.2023.105469_bib0036","doi-asserted-by":"crossref","first-page":"e43393","DOI":"10.1371\/journal.pone.0043393","article-title":"Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients","volume":"7","author":"Campitelli","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jcv.2023.105469_bib0037","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/ijms18102032","article-title":"Viral-cellular DNA junctions as molecular markers for assessing intra-tumor heterogeneity in cervical cancer and for the detection of circulating tumor DNA","volume":"18","author":"Carow","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0038","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s40944-018-0245-2","article-title":"Cell-free circulating tumor DNA mutation profiling for cervical carcinoma as diagnostic biomarker: a 50-gene module to future directive","volume":"17","author":"Govardhan","year":"2019","journal-title":"Ind. J. Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.jcv.2023.105469_bib0039","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/ijc.32295","article-title":"Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancer","volume":"145","author":"Tian","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2023.105469_bib0040","article-title":"A study for evaluating clinical relevance of circulating cell-free DNA in cervical cancer","author":"Shrivastava","year":"2020","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.jcv.2023.105469_bib0041","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s12885-020-07161-0","article-title":"Efficient mutation screening for cervical cancers from circulating tumor DNA in blood","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jcv.2023.105469_bib0042","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.33362","article-title":"Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer","volume":"148","author":"Tian","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.jcv.2023.105469_bib0043","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-18-2984","article-title":"Clinical validity of HPV circulating tumor DNA in advanced anal carcinoma: an ancillary study to the epitopes-HPV02 trial","volume":"25","author":"Bernard-Tessier","year":"2019","journal-title":"Clin. Cancer Res. Offic. J. Am. Assoc. Cancer Res."},{"issue":"22","key":"10.1016\/j.jcv.2023.105469_bib0044","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1158\/1078-0432.CCR-18-0922","article-title":"Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma","volume":"24","author":"Cabel","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2023.105469_bib0045","article-title":"Detection of early human papillomavirus-Associated cancers by liquid biopsy","volume":"3","author":"Damerla","year":"2019","journal-title":"JCO Precis. Oncol."},{"issue":"4","key":"10.1016\/j.jcv.2023.105469_bib0046","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/ijgc-2020-001285","article-title":"World Health Organization call for action to eliminate cervical cancer globally","volume":"30","author":"Gultekin","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.jcv.2023.105469_bib0047","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11912-014-0402-4","article-title":"The burden of HPV-associated anogenital cancers","volume":"16","author":"Wakeham","year":"2014","journal-title":"Curr. Oncol. Rep."},{"issue":"9","key":"10.1016\/j.jcv.2023.105469_bib0048","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/life11090890","article-title":"Liquid biopsy, ctDNA diagnosis through NGS","volume":"11","author":"Lin","year":"2021","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.jcv.2023.105469_bib0049","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/C8LC00100F","article-title":"Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies","volume":"18","author":"Gorgannezhad","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.jcv.2023.105469_bib0050","first-page":"1","article-title":"Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions","author":"Herbst","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"7629","key":"10.1016\/j.jcv.2023.105469_bib0051","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"Bmj"},{"key":"10.1016\/j.jcv.2023.105469_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.34199","article-title":"A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups","author":"Clarke","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.jcv.2023.105469_bib0053","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-21-2426","article-title":"Liquid biopsy for cancer detection: clinical and epidemiologic considerations","volume":"27","author":"Wentzensen","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2023.105469_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106679","article-title":"Design of the ANal Cancer\/HSIL Outcomes Research study (ANCHOR study): a randomized study to prevent anal cancer among persons living with HIV","volume":"113","author":"Lee","year":"2022","journal-title":"Contemp. Clin. Trials"},{"issue":"24","key":"10.1016\/j.jcv.2023.105469_bib0055","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N. Engl. J. Medic."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:17:28Z","timestamp":1761362248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653223000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":55,"alternative-id":["S1386653223000926"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105469","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105469"}}